BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10096969)

  • 1. A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers.
    D'Amico TA; Massey M; Herndon JE; Moore MB; Harpole DH
    J Thorac Cardiovasc Surg; 1999 Apr; 117(4):736-43. PubMed ID: 10096969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biologic substaging of stage I lung cancer according to gender and histology.
    D'Amico TA; Aloia TA; Moore MB; Herndon JE; Brooks KR; Lau CL; Harpole DH
    Ann Thorac Surg; 2000 Mar; 69(3):882-6. PubMed ID: 10750777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological markers in non-small cell lung cancer. Retrospective study of 10 year follow-up after surgery.
    Carbognani P; Tincani G; Crafa P; Sansebastiano G; Pazzini L; Zoni R; Bobbio A; Rusca M
    J Cardiovasc Surg (Torino); 2002 Aug; 43(4):545-8. PubMed ID: 12124571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer.
    Harpole DH; Richards WG; Herndon JE; Sugarbaker DJ
    Ann Thorac Surg; 1996 May; 61(5):1470-6. PubMed ID: 8633961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical markers in stage I lung cancer: relevance to prognosis.
    Pastorino U; Andreola S; Tagliabue E; Pezzella F; Incarbone M; Sozzi G; Buyse M; Menard S; Pierotti M; Rilke F
    J Clin Oncol; 1997 Aug; 15(8):2858-65. PubMed ID: 9256129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological prognostic factors for early stage completely resected non-small cell lung cancer.
    Cagini L; Monacelli M; Giustozzi G; Moggi L; Bellezza G; Sidoni A; Bucciarelli E; Darwish S; Ludovini V; Pistola L; Gregorc V; Tonato M
    J Surg Oncol; 2000 May; 74(1):53-60. PubMed ID: 10861611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
    Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
    Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of chemoresistance markers in patients with stage III non-small cell lung cancer: a novel approach for patient selection.
    Brooks KR; To K; Joshi MB; Conlon DH; Herndon JE; D'Amico TA; Harpole DH
    Ann Thorac Surg; 2003 Jul; 76(1):187-93; discussion 193. PubMed ID: 12842538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Useful prognostic panel markers to express the biological tumor status in resected lung adenocarcinomas.
    Carvalho PE; Antonãngelo L; Bernardi FD; Leão LE; Rodrigues OR; Capelozzi VL
    Jpn J Clin Oncol; 2000 Nov; 30(11):478-86. PubMed ID: 11155917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and molecular predictors of recurrence in stage I non-small cell lung cancer.
    Starnes SL; Pathrose P; Wang J; Succop P; Morris JC; Bridges J; Kupert EY; Anderson M
    Ann Thorac Surg; 2012 May; 93(5):1606-12. PubMed ID: 22440368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of recurrence in patients with surgically resected stage I non-small cell lung carcinoma: histopathologic and immunohistochemical analysis.
    Poleri C; Morero JL; Nieva B; Vázquez MF; Rodríguez C; de Titto E; Rosenberg M
    Chest; 2003 Jun; 123(6):1858-67. PubMed ID: 12796161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of non-small cell lung cancer: correlation with clinical parameters and prognosis.
    Yoo J; Jung JH; Lee MA; Seo KJ; Shim BY; Kim SH; Cho DG; Ahn MI; Kim CH; Cho KD; Kang SJ; Kim HK
    J Korean Med Sci; 2007 Apr; 22(2):318-25. PubMed ID: 17449943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Effect of Lymphovascular Invasion on TNM Staging in Stage I Non-Small-cell Lung Cancer.
    Noma D; Inamura K; Matsuura Y; Hirata Y; Nakajima T; Yamazaki H; Hirai Y; Ichinose J; Nakao M; Ninomiya H; Mun M; Nakagawa K; Masuda M; Ishikawa Y; Okumura S
    Clin Lung Cancer; 2018 Jan; 19(1):e109-e122. PubMed ID: 29066222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non-Small-Cell Lung Cancer.
    Dziedzic DA; Rudzinski P; Langfort R; Orlowski T;
    Clin Lung Cancer; 2016 Sep; 17(5):e157-e167. PubMed ID: 26831834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer.
    Duarte IG; Bufkin BL; Pennington MF; Gal AA; Cohen C; Kosinski AS; Mansour KA; Miller JI
    J Thorac Cardiovasc Surg; 1998 Mar; 115(3):652-8; discussion 658-9. PubMed ID: 9535454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell proliferation and apoptosis in stage III inoperable non-small cell lung carcinoma treated by radiotherapy.
    Langendijk H; Thunnissen E; Arends JW; de Jong J; ten Velde G; Lamers R; Guinee D; Holden J; Wouters M
    Radiother Oncol; 2000 Aug; 56(2):197-207. PubMed ID: 10927139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non-small cell lung cancer.
    Bozcuk H; Gumus A; Ozbilim G; Sarper A; Kucukosmanoglu I; Ozbudak IH; Artac M; Ozdogan M; Samur M; Kaya A; Savas B
    Med Sci Monit; 2005 Jun; 11(6):HY11-20. PubMed ID: 15917726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of nuclear factor of activated T-cells 5 expression in non-small cell lung cancer patients who underwent surgical resection.
    Cho HJ; Yun HJ; Yang HC; Kim SJ; Kang SK; Che C; Lee SD; Kang MW
    J Surg Res; 2018 Jun; 226():40-47. PubMed ID: 29661287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer.
    Kong F; Gao F; Chen J; Sun Y; Zhang Y; Liu H; Li X; Yang P; Zheng R; Liu G; Jia Y
    Oncotarget; 2016 Aug; 7(35):56193-56199. PubMed ID: 27486880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
    Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
    Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.